IDEXX Laboratories, Inc.
IDXX
NASDAQ·Healthcare·Medical - Diagnostics & Research·Mkt cap $42.5B
$538.99
▼ -1.13%
P/E
83.56
Mkt Cap
$42.5B
52-Wk Range
$518.55–$769.98
52-Week Range
$518.55 - $769.98
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 15.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Comprehensive veterinary diagnostic ecosystem
- Advanced proprietary testing technologies
- Strong global distribution network
- Continuous innovation in animal healthcare
Bear Case
2 risks
- Above-average volatility (beta 1.5).
- Premium valuation to Life Sciences Tools peers
Growth
Stable outlook
Increasing pet ownership and veterinary care spending
Value
Premium valuation to Life Sciences Tools peers
Momentum
Stable
-3.9% over 3m
Quality
Excellent
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying IDXX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 2, 2026
AUG 4, 2026
Reported EPS of $4.27 vs $3.94 consensus (+8.4% surprise). Revenue of $1.2B vs $1.2B expected (+1.4%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+8.4%
Revenue trend · last 8Q
—
+6%
+4%
+11%
+13%
+14%
+14%
+10%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$975.5M
$954.3M
$998.4M
$1.1B
$1.1B
$1.1B
$1.1B
$1.2B
Margins · last 8Q
Gross
64.0%
Operating
35.0%
Profit
27.8%
Wall Street consensus
4 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
50%
Sell
0%
Median Price Target
—
Latest: Barclays · Aug 11, 2026
vs Industry
How IDXX stacks vs Medical - Diagnostics & Research
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related